In particular, previous study have shown that miR-216a promotes invasion and metastasis in hepatocellular carcinoma through targeting TSLC1, PTEN, and SMAD7 (25–27), which is further confirmed in a variety of cell models (28–30). Here, SMAD7 is linked to hepatocellular carcinoma.